Dong Soo Park

CHA University Bundang Medical Center

Papers

1

Total Citations

24

H-Index

1

About

Dr. Dong Soo Park is a distinguished urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for renal cell carcinoma. His primary research areas include focal therapy, robot-assisted partial nephrectomy, and the comparative effectiveness of nephron-sparing approaches for small renal masses. Dr. Park’s major contribution lies in directly comparing focal therapy and robot-assisted partial nephrectomy for clinical T1 renal tumors, providing critical evidence that both modalities offer effective oncologic control while preserving renal function. His landmark 2018 study, which has garnered 24 citations, is among the few head-to-head analyses in the era of minimally invasive surgery, helping guide clinical decision-making for patients with small renal masses. Beyond this work, Dr. Park has been instrumental in refining surgical techniques and patient selection criteria for partial nephrectomy, contributing to improved outcomes and reduced morbidity. His research has been widely recognized in the urologic community, and his comparative studies continue to shape treatment paradigms, offering patients less invasive options without compromising cancer control. Dr. Park’s dedication to evidence-based surgical innovation makes him a respected voice in the field of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Focal therapy versus robot-assisted partial nephrectomy in the management of clinical T1 renal masses
24 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: CHA University Bundang Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago